A serial optical frequency-domain imaging study of early and late vascular responses to bioresorbable-polymer sirolimus-eluting stents for the treatment of acute myocardial infarction and stable coronary artery disease patients: results of the MECHANISM-ULTIMASTER study

Cardiovasc Interv Ther. 2022 Apr;37(2):281-292. doi: 10.1007/s12928-021-00777-4. Epub 2021 Apr 25.

Abstract

The purpose of this study was to assess early and late vascular healing in response to bioresorbable-polymer sirolimus-eluting stents (BP-SESs) for the treatment of patients with ST-elevation myocardial infarction (STEMI) and stable coronary artery disease (CAD). A total of 106 patients with STEMI and 101 patients with stable-CAD were enrolled. Optical frequency-domain images were acquired at baseline, at 1- or 3-month follow-up, and at 12-month follow-up. In the STEMI and CAD cohorts, the percentage of uncovered struts (%US) was significantly and remarkably decreased during early two points and at 12-month (the STEMI cohort: 1-month: 18.75 ± 0.78%, 3-month: 10.19 ± 0.77%, 12-month: 1.80 ± 0.72%; p < 0.001, the CAD cohort: 1-month: 9.44 ± 0.78%, 3-month: 7.78 ± 0.78%, 12-month: 1.07 ± 0.73%; p < 0.001 respectively). The average peri-strut low-intensity area (PLIA) score in the STEMI cohort was significantly decreased during follow-up period (1.90 ± 1.14, 1.18 ± 1.25, and 1.01 ± 0.72; p ≤ 0.001), whereas the one in the CAD cohort was not significantly changed (0.89 ± 1.24, 0.67 ± 1.07, and 0.64 ± 0.72; p = 0.59). In comparison with both groups, differences of %US and PLIA score at early two points were almost disappeared or close at 12 months. The strut-coverage and healing processes in the early phase after BP-SES implantation were significantly improved in both cohorts, especially markedly in STEMI patients. At 1 year, qualitatively and quantitatively consistent neointimal coverage was achieved in both pathogenetic groups.

Keywords: Bioresorbable-polymer sirolimus-eluting stents; Optical frequency-domain images; ST-elevation myocardial infarction; Stable coronary artery disease.

MeSH terms

  • Absorbable Implants
  • Coronary Artery Disease* / diagnosis
  • Coronary Artery Disease* / surgery
  • Drug-Eluting Stents*
  • Humans
  • Myocardial Infarction* / etiology
  • Myocardial Infarction* / surgery
  • Percutaneous Coronary Intervention* / methods
  • Polymers
  • Sirolimus / adverse effects
  • Stents
  • Tomography, Optical Coherence / methods
  • Treatment Outcome

Substances

  • Polymers
  • Sirolimus